InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.245 0.005 (2.08%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$146 Change in substantial holding 21 Feb 2017 8:18AM $0.008 $0.243 risen by 2,931.25%
$146 Change in substantial holding 20 Feb 2017 11:18AM $0.008 $0.243 risen by 2,931.25%
$146 Corporate Presentation 14 Feb 2017 9:38AM $0.008 $0.243 risen by 2,931.25%
$146 Shareholder Newsletter 7 Feb 2017 8:27AM $0.008 $0.243 risen by 2,931.25%
$146 LR 3.10.5A Disclosure 6 Feb 2017 10:16AM $0.008 $0.243 risen by 2,931.25%
$146 Appendix 3B and Cleansing Notice 6 Feb 2017 10:07AM $0.008 $0.243 risen by 2,931.25%
$146 Key Patent Allowed in Japan 31 Jan 2017 10:04AM $0.008 $0.243 risen by 2,931.25%
$146 Company Presentation 25 Jan 2017 9:38AM $0.008 $0.243 risen by 2,931.25%
$146 Dimerix Raises $2 million to Advance Clinical Program 25 Jan 2017 9:36AM $0.008 $0.243 risen by 2,931.25%
$146 Trading Halt 23 Jan 2017 9:26AM $0.008 $0.243 risen by 2,931.25%
$146 Appendix 4C - quarterly 23 Jan 2017 8:24AM $0.008 $0.243 risen by 2,931.25%
$146 Dimerix Receptor-HIT data presented by Takeda 14 Dec 2016 9:04AM $0.008 $0.243 risen by 2,931.25%
$146 Change of Share Registry Address 9 Dec 2016 1:36PM $0.008 $0.243 risen by 2,931.25%
$146 Recruitment of Part A of Phase 2 Trial of DMX-200 Completed 6 Dec 2016 10:09AM $0.008 $0.243 risen by 2,931.25%
$146 Appointment of Chief Executive Officer 7 Nov 2016 8:26AM $0.009 $0.243 risen by 2,594.44%
$146 Results of Meeting 4 Nov 2016 2:18PM $0.009 $0.243 risen by 2,594.44%
$146 Final Director's Interest Notice 3 Nov 2016 7:52PM $0.009 $0.243 risen by 2,594.44%
$146 Director Resignation 3 Nov 2016 7:45PM $0.009 $0.243 risen by 2,594.44%
$146 Appendix 4C - quarterly 31 Oct 2016 12:47AM $0.010 $0.243 risen by 2,325%
$146 Shareholder Newsletter 31 Oct 2016 12:43AM $0.010 $0.243 risen by 2,325%
$146 New Equity Research Report Published 19 Oct 2016 8:25AM $0.010 $0.243 risen by 2,325%
$146 Update presentation - interim data 11 Oct 2016 8:00PM $0.011 $0.243 risen by 2,104.55%
$146 Positive interim analysis of DMX-200 phase II data 4 Oct 2016 8:40AM $0.015 $0.243 risen by 1,516.67%
$146 Notice of Annual General Meeting/Proxy Form 21 Sep 2016 11:24AM $0.016 $0.243 risen by 1,415.63%
$146 Appendix 4G and Corporate Governance Statement 19 Sep 2016 8:25AM $0.016 $0.243 risen by 1,415.63%

651 - 675 of 719 results

Page 27 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.